KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.

A new interesting article has been published in Eur Rev Med Pharmacol Sci. 2019 May;23(9):3867-3875. doi: 10.26355/eurrev_201905_17814. and titled: KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells…

Continue Reading KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.

Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.

A new interesting article has been published in J Urol. 2019 May 21:101097JU0000000000000351. doi: 10.1097/JU.0000000000000351. and titled: Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from…

Continue Reading Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.

Protective effect of 3,5‑dicaffeoyl‑epi‑quinic acid against UVB‑induced photoaging in human HaCaT keratinocytes.

A new interesting article has been published in Mol Med Rep. 2019 May 21. doi: 10.3892/mmr.2019.10258. and titled: Protective effect of 3,5‑dicaffeoyl‑epi‑quinic acid against UVB‑induced photoaging in human HaCaT keratinocytes.…

Continue Reading Protective effect of 3,5‑dicaffeoyl‑epi‑quinic acid against UVB‑induced photoaging in human HaCaT keratinocytes.

ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.

A new interesting article has been published in Mol Med Rep. 2019 May 9. doi: 10.3892/mmr.2019.10226. and titled: ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX…

Continue Reading ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.